Patent details

EP1265633 Title: ADJUVANT FOR VACCINES

Basic Information

Publication number:
EP1265633
PCT Application Number:
PCT/EP/2001/002866
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019315225
PCT Publication Number:
WO/2001/068129
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
ADJUVANT FOR VACCINES
French Title of Invention:
ADJUVANT POUR VACCINS
German Title of Invention:
ADJUVANS FÜR VAKZINEN
SPC Number:

Dates

Filing date:
14/03/2001
Grant date:
12/12/2012
EP Publication Date:
12/12/2012
PCT Publication Date:
20/09/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/12/2002
EP B1 Publication Date:
12/12/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/03/2014
Expiration date:
14/03/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/03/2001
 
 

Name:
Novartis Vaccines and Diagnostics GmbH
Address:
Emil-von-Behring-Strasse 76, 35041 Marburg, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/12/2012
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
BROKER Michael
Address:
Germany (DE)

Priority

Priority Number:
10012370
Priority Date:
14/03/2000
Priority Country:
Germany (DE)

Classification

Main IPC Class:
A61K 39/39;
Filing date Document type Number of pages